Cardano Just Launched Major Scaling Testnet, Markets React
Cardano rolled out a major scaling testnet this week, aiming to boost throughput amid mixed market signals. ADA trade...
Ways To Review Your Savings Progress
Regularly reviewing your savings progress is essential for success. Discover effective methods to keep track of your financial journey.
20,681 articles
Fermi America Sinks 11.5% on $375M Convertible Offering
Fermi America slumped 11.5% as it unveiled a $375 million convertible note offering and reported a Q1 with zero reven...
Iridium, Spacemobile, Redwire Lead February Moves
February highlighted a split in space stocks: Iridium rose on stabilizing results, while Redwire and Spacemobile tumb...
Lululemon's Corporate Struggles Continue: Is a Turnaround Near?
Lululemon faces renewed headwinds as leadership shifts and governance questions surface. This comprehensive look brea...
AST SpaceMobile Earnings Miss Triggers Spacemobile Decline
AST SpaceMobile posted disappointing quarterly revenue in after-hours trading, triggering a drop in spacemobile’s sto...
Target’s Turnaround Smooth? Investors Remain Skeptical
Target rolls out a broad turnaround, including redesigned carts and a baby concierge service, but investors question ...
Can’t SpaceX Yet? Wall Street Names the Next Best Space Stock
As SpaceX gears up for a potential June 2026 IPO, investors are flocking to Rocket Lab as the leading public substitu...
Prediction: Broadcom Shares Could Reach $550 by 2027
Broadcom reported a strong quarter with AI chip sales up sharply, fueling optimism about a potential move toward $550...
Wall Street Just Panic-Dumped CRM: The AI Bargain I’m Loading Up
Salesforce CRM faces a sharp sell-off even as its AI strategy shows real monetization. Here’s why traders are watchin...
Wendy’s McDonald’s: Wendy’s Ride to Short-Squeeze Momentum
Wendy’s faces traffic losses even as it pursues a turnaround with Project Fresh, while McDonald’s leans on loyalty an...
SPX Technologies Jump as JPMorgan Initiates with Overweight
JPMorgan initiates SPX Technologies with an Overweight rating and a $260 target, signalling a favorable view on data-...
Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status